Memorializing Governor Kathy Hochul to proclaim March 2026, as Kidney Disease Awareness Month in the State of New York
Senate Resolution No. 1793 is a memorializing resolution that asks Governor Kathy Hochul to proclaim March 2026 as Kidney Disease Awareness Month in New York State, in conjunction with National Kidney Month. The resolution is primarily commemorative and educational: it describes chronic kidney disease (CKD), end-stage renal disease (ESRD), dialysis, kidney transplantation, and the importance of early detection and intervention. It also highlights the role of kidney disease awareness organizations and encourages public attention to organ and tissue donation.
The resolution emphasizes the public health burden of kidney disease, noting that it affects millions of Americans and disproportionately impacts Black, Native American, Hispanic, and older populations. It also references APOL1 gene variants and their association with increased kidney disease risk, as well as the links between CKD, diabetes, hypertension, and cardiovascular disease. The measure does not create a new program, mandate, or funding stream; instead, it seeks a gubernatorial proclamation and public recognition of kidney disease awareness efforts.
This resolution would not directly amend the New York Consolidated Laws or impose legal obligations on agencies, health providers, or residents. Its practical effect is symbolic and promotional: it would add state-level recognition to Kidney Disease Awareness Month and may help support public education, screening awareness, organ donation outreach, and advocacy by kidney health organizations. The affected parties are primarily patients, caregivers, public health advocates, and organizations such as kidney foundations and transplant-related groups.
The overall sentiment around the resolution is strongly supportive and noncontroversial. The text frames kidney disease as a serious and often underdiagnosed condition and presents the proclamation as a way to increase awareness, encourage early testing, and recognize affected communities. No votes or committee transcripts were provided, but the resolution’s tone and purpose suggest broad bipartisan or unanimous support typical of awareness resolutions.
No specific opposition or controversy is reflected in the available record. The only potentially sensitive policy-related themes are the emphasis on racial and ethnic disparities, the mention of APOL1 genetic risk factors, and the focus on organ donation and transplant access, but the resolution itself does not propose regulatory changes or allocate resources. As a result, there is little evident room for legislative contention in the text provided.